spiradoline has been researched along with cyclohexanol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braida, D; Capurro, V; Parolaro, D; Rubino, T; Sala, M; Viganò, D; Zani, A | 1 |
| France, CP; Maguire, DR | 1 |
| Dahal, S; France, CP; Minervini, V | 1 |
3 other study(ies) available for spiradoline and cyclohexanol
| Article | Year |
|---|---|
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Binding, Competitive; Brain; Cyclohexanols; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Emotions; Injections, Subcutaneous; Male; Mice; Models, Animal; Motor Activity; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Salvia; Swimming | 2009 |
Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
Topics: Analgesics; Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hot Temperature; Male; Nociceptive Pain; Pain Threshold; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2016 |
Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Cyclohexanols; Drug Synergism; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Opioid, kappa | 2017 |